Previous studies have shown that GLP-1 RA therapy lowers both systolic and diastolic blood pressure [71], improves endothelial dysfunction [72, 73], and reduces macrophage foam cell formation and atherosclerosis [74]. This evidence concerns the gene GLP1R and atherosclerosis.